Bot Image
About Bot Image
Bot Image is a medical artificial intelligence company specializing in the interpretation of magnetic resonance imaging (MRI) for healthcare providers. Their flagship product, ProstatID™, is an FDA-cleared software designed to assist physicians in the detection, diagnosis, and screening of prostate cancer using both multi-parametric and bi-parametric MRI. The software utilizes advanced AI algorithms, including random forest with instance weighting and deep learning with nested networks for MR segmentation, to analyze prostate MRI data. ProstatID™ aims to improve the accuracy of prostate cancer detection and reduce false positives by providing a 3D view of the prostate with identified suspicious lesions, along with index scores indicating the likelihood of cancer. This technology is designed to integrate seamlessly into existing PACS, MRI, and viewing stations, offering near real-time diagnostic outputs as a software-as-a-service (SaaS) model.
For physicians, Bot Image’s ProstatID™ offers a valuable tool to enhance the interpretation of prostate MRIs, potentially leading to earlier and more precise intervention for prostate cancer. The software’s ability to provide detailed 3D tumor modeling and lesion identification can assist oncologists in treatment planning and targeting, and urologists in guiding cognitive biopsies. The company emphasizes that ProstatID™ is the first and only software FDA-cleared for detection, diagnosis, and screening of prostate cancer using fast, inexpensive bi-parametric MRI (bpMRI). This technology was initially developed at the National Institutes of Health (NIH) and has demonstrated high accuracy in pilot studies, outperforming seasoned radiologists in some instances. Bot Image also partners with platforms like DeepView Imaging to offer direct-to-consumer AI analysis of prostate MRIs for patients to discuss with their clinicians.
Focus Areas
Business Intelligence
| Partnerships | Blackford, ConcertAI's TeraRecon, DeepView Imaging, 3DR Labs |
| Technology | Cloud-based, AI operating system (using random forest with instance weight and deep learning with holistically-nested networks for MR segmentation) |
| FDA Clearances | 1 (ProstatID™ for detection, diagnosis, and monitoring of prostate cancer) cleared products (estimated) |
What Physicians Need to Know
For physicians, Bot Image's ProstatIDu2122 offers a powerful tool to significantly improve the accuracy and efficiency of prostate MRI interpretation. It provides a colorized overlay of suspicious lesions with cancer risk scores and PI-RADS scores, aiding in early detection, diagnosis, active surveillance, and treatment planning. The rapid turnaround time of less than five minutes allows for real-time diagnostic assistance, potentially enabling physicians to review results while the patient is still undergoing the MRI. The 3D tumor modeling can greatly assist oncologists in treatment planning and targeting, and urologists in guiding biopsies. Furthermore, the use of non-contrast bpMRI with AI can reduce costs associated with contrast agents and interpretation time, while also decreasing false positives and unwarranted biopsies.
Bot Image is actively working with several MRI systems and agnostic Advanced Visualization and Artificial Intelligence platform providers to integrate their 'dockerized' application into existing systems across the US, Europe, and elsewhere. They also partner with companies like DeepView Imaging to offer direct-to-consumer AI analysis of prostate MRIs, and with platforms like Blackford and ConcertAI's TeraRecon Eureka Clinical AI platform to expand the reach of ProstatIDu2122.
Reviews & Opinions
Videos
News, demos, and interviews about Bot Image.
Videos load interactively. If none appear, search YouTube for Bot Image →
Press & Coverage
Frequently Asked Questions
Comparisons
When choosing between Avenda Health AI Prostate Cancer Planning Software (Unfold AI) and Bot Image’s ProstatID, physicians should consider their primary need: comprehensive treatment planning versus initial detection and risk assessment. Avenda Health’s Unfold AI excels at creating detailed 3D cancer maps from various patient data, including MRI, biopsy, pathology, and PSA. This tool is […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]